Eun Yang
Stock Analyst at Jefferies
(0.39)
# 3,291
Out of 4,479 analysts
38
Total ratings
35.71%
Success rate
-25.84%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTE Aerovate Therapeutics | Downgrades: Hold | $65 → $2 | $1.62 | +23.46% | 3 | Jun 17, 2024 | |
| TSHA Taysha Gene Therapies | Assumes: Buy | $2 → $8 | $2.16 | +270.37% | 2 | May 14, 2024 | |
| ATXS Astria Therapeutics | Maintains: Buy | $22 → $27 | $8.97 | +201.00% | 2 | Mar 25, 2024 | |
| RLYB Rallybio | Downgrades: Hold | $7 → $1.5 | $1.20 | +25.00% | 2 | Feb 7, 2024 | |
| RPHM Reneo Pharmaceuticals | Downgrades: Hold | $17 → $1.8 | $1.51 | +19.21% | 2 | Dec 15, 2023 | |
| BBIO BridgeBio Pharma | Downgrades: Hold | $24 → $33 | $24.91 | +32.48% | 1 | Jul 18, 2023 | |
| BMEA Biomea Fusion | Downgrades: Hold | $36 → $28 | $4.43 | +532.05% | 2 | Jun 26, 2023 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $27 | $21.70 | +24.42% | 1 | Mar 29, 2023 | |
| GNSS Genasys | Maintains: Outperform | $6 → $7 | $2.56 | +173.44% | 1 | Feb 10, 2023 | |
| CVAC CureVac | Upgrades: Buy | n/a | $3.34 | - | 2 | Jan 9, 2023 | |
| LUMO Lumos Pharma | Downgrades: Hold | $17 → $7 | $2.27 | +208.37% | 3 | Dec 8, 2022 | |
| PRME Prime Medicine | Initiates: Buy | $25 | $5.28 | +373.48% | 1 | Nov 14, 2022 | |
| NCNA NuCana | Maintains: Buy | $525 → $75 | $2.57 | +2,818.29% | 1 | Sep 22, 2022 | |
| BPMC Blueprint Medicines | Maintains: Buy | $78 → $84 | $110.36 | -23.89% | 3 | Aug 22, 2022 | |
| UTHR United Therapeutics | Maintains: Buy | $223 → $245 | $317.05 | -22.73% | 3 | May 24, 2022 | |
| PYXS Pyxis Oncology | Initiates: Buy | n/a | $2.94 | - | 1 | Nov 2, 2021 | |
| VERV Verve Therapeutics | Initiates: Buy | n/a | $5.00 | - | 1 | Jul 12, 2021 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | n/a | $8.77 | - | 1 | Jun 22, 2021 | |
| AMGN Amgen | Maintains: Buy | n/a | $310.77 | - | 2 | Jul 27, 2018 | |
| RDUS Radius Health | Maintains: Hold | n/a | $14.67 | - | 1 | Nov 3, 2017 | |
| ALRN Aileron Therapeutics | Initiates: Buy | n/a | $2.76 | - | 1 | Jul 24, 2017 | |
| BIIB Biogen | Assumes: Hold | n/a | $228.82 | - | 1 | Jul 11, 2017 | |
| GILD Gilead Sciences | Assumes: Hold | n/a | $68.40 | - | 1 | Jul 11, 2017 |
Aerovate Therapeutics
Jun 17, 2024
Downgrades: Hold
Price Target: $65 → $2
Current: $1.62
Upside: +23.46%
Taysha Gene Therapies
May 14, 2024
Assumes: Buy
Price Target: $2 → $8
Current: $2.16
Upside: +270.37%
Astria Therapeutics
Mar 25, 2024
Maintains: Buy
Price Target: $22 → $27
Current: $8.97
Upside: +201.00%
Rallybio
Feb 7, 2024
Downgrades: Hold
Price Target: $7 → $1.5
Current: $1.20
Upside: +25.00%
Reneo Pharmaceuticals
Dec 15, 2023
Downgrades: Hold
Price Target: $17 → $1.8
Current: $1.51
Upside: +19.21%
BridgeBio Pharma
Jul 18, 2023
Downgrades: Hold
Price Target: $24 → $33
Current: $24.91
Upside: +32.48%
Biomea Fusion
Jun 26, 2023
Downgrades: Hold
Price Target: $36 → $28
Current: $4.43
Upside: +532.05%
Enliven Therapeutics
Mar 29, 2023
Initiates: Buy
Price Target: $27
Current: $21.70
Upside: +24.42%
Genasys
Feb 10, 2023
Maintains: Outperform
Price Target: $6 → $7
Current: $2.56
Upside: +173.44%
CureVac
Jan 9, 2023
Upgrades: Buy
Price Target: n/a
Current: $3.34
Upside: -
Lumos Pharma
Dec 8, 2022
Downgrades: Hold
Price Target: $17 → $7
Current: $2.27
Upside: +208.37%
Prime Medicine
Nov 14, 2022
Initiates: Buy
Price Target: $25
Current: $5.28
Upside: +373.48%
NuCana
Sep 22, 2022
Maintains: Buy
Price Target: $525 → $75
Current: $2.57
Upside: +2,818.29%
Blueprint Medicines
Aug 22, 2022
Maintains: Buy
Price Target: $78 → $84
Current: $110.36
Upside: -23.89%
United Therapeutics
May 24, 2022
Maintains: Buy
Price Target: $223 → $245
Current: $317.05
Upside: -22.73%
Pyxis Oncology
Nov 2, 2021
Initiates: Buy
Price Target: n/a
Current: $2.94
Upside: -
Verve Therapeutics
Jul 12, 2021
Initiates: Buy
Price Target: n/a
Current: $5.00
Upside: -
Centessa Pharmaceuticals
Jun 22, 2021
Initiates: Buy
Price Target: n/a
Current: $8.77
Upside: -
Amgen
Jul 27, 2018
Maintains: Buy
Price Target: n/a
Current: $310.77
Upside: -
Radius Health
Nov 3, 2017
Maintains: Hold
Price Target: n/a
Current: $14.67
Upside: -
Aileron Therapeutics
Jul 24, 2017
Initiates: Buy
Price Target: n/a
Current: $2.76
Upside: -
Biogen
Jul 11, 2017
Assumes: Hold
Price Target: n/a
Current: $228.82
Upside: -
Gilead Sciences
Jul 11, 2017
Assumes: Hold
Price Target: n/a
Current: $68.40
Upside: -